CCRM

📍 Toronto, Canada🗓 Founded 2011👥 205 employees💰 Last funded Feb 2019
Biotechnology Research🌐 ccrm.ca
Website LinkedIn
Regenerative Medicine (RM), which aims to harness the power of stem cells, biomaterials and molecules to repair, regenerate or replace diseased cells, tissues and organs, has the promise to treat, manage and perhaps cure some of the most devastating and costly diseases in the world today. Many new and potentially life-changing RM-based treatments never reach patients because they are not successfully moved from the laboratory to a stage where they can be used in medicine. In order to fulfill RM’s promise to treat the many diseases affecting our population, a world-renowned group of stem cell scientists and engineers have come together to form CCRM, a leader in developing and commercializing regenerative medicine and cell therapy technologies. CCRM formally launched on June 14, 2011. CCRM supports the development and commercialization of regenerative medicines and associated enabling technologies, with a specific focus on cell and gene therapy.
5
Total investors
0
Early stage
1
Mid stage
4
Late stage
2011
Founded

Investors

5 investors
All
Early stage
Mid stage
Late stage
Investor geography3 countries
Canada
2
United Kingdom
1
United States
1
Investor activity2015–2019 · investors recorded per year
20151201712018220191
Recent (last 2y)Earlier
Frequently asked questions
Who invested in CCRM?
CCRM has 5 investors on record on gritt.io, 1 mid-stage and 4 late-stage investors.
When did CCRM last raise funding?
The most recent investment in CCRM recorded on gritt.io was in February 2019.
When was CCRM founded?
CCRM was founded in 2011.
What industry is CCRM in?
CCRM operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is CCRM based?
CCRM is headquartered in Toronto, Canada.